Inamul Haque

About

Inamul Haque was born on January 1, 1974 at Supaul Bazar in Darbhanga (India). Dr. Haque received his BSc (1994), MSc (1996) and B. Ed (1998) in Biosciences from Jamia Millia Islamia, a Central University in New Delhi. He received a Ph. D in 2005 under the supervision of Professor Faizan Ahmad, a great protein chemist. He then moved to USA in 2006 to join Dr. Mark T. Fisher’s lab at University of Kansas Medical Center, Kansas City, Kansas, USA. Currently, Dr. Haque is a Research Scientist at VA Medical Center, Kansas City, and has a joint appointment as an Assistant Professor in the University of Kansas Medical Center. He is particularly interested in the regulation and function of two of CCN family members, i.e., CCN1 and CCN5 in mediating epithelial to Mesenchymal transition and SHh signaling. An additional area of research in his lab is focused on the role of microRNAs (small non-coding RNAs) in the regulation of invasive phenotypes in breast as well as in pancreatic cancer.

Employment

Employment history is unavailable.

Education

• Jamia Millia Islamia PhD
  1999 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development
  International Journal of Molecular Sciences 2024 DOI: 10.3390/ijms25116078
  +Save
• CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.
  Oncogenesis 2017
  +Save
• Current and emerging perspectives on immunotherapy for pancreatic cancer
  Translational Cancer Research 2017 DOI: 10.21037/tcr.2017.03.48
  +Save
• Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth
  Scientific Reports 2017 DOI: 10.1038/s41598-017-00916-z
  +Save
• Human pancreatic cancer progression: an anarchy among CCN-siblings
  Journal of Cell Communication and Signaling 2016 DOI: 10.1007/s12079-016-0343-9
  +Save
• The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression
  International journal of molecular sciences 2016 DOI: 10.3390/ijms17060809
  +Save
• CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27 Kip1 via Skp2 and FOXO3a regulation
  Oncogene 2015 DOI: 10.1038/onc.2014.250
  +Save
• Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization
  Scientific Reports 2014 DOI: 10.1038/srep04995
  +Save
• Photocontrol of differential gene expression and alterations in foliar anthocyanin accumulation: A comparative study using red and green forma Ocimum tenuiflorum
  Acta Physiologiae Plantarum 2014 DOI: 10.1007/s11738-014-1586-9
  +Save
• A second-generation 2-methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a Mouse Xenograft Model
  Molecular Cancer Therapeutics 2013 DOI: 10.1158/1535-7163.MCT-12-0777
  +Save